InMode falls as slowing N.America sales prompt forecast cuts
** Shares of Israel-based medtech co Inmode fall ~13% to
$20.59 in premarket trading
** Co cuts annual sales and adj. profit expectations, citing
slowdown in sales in North America
** INMD now sees 2023 revenue to be in the range of $485 mln
to $495 mln vs prior estimated range of $500 mln to $510 mln
** Analysts were expecting 2023 revenue of $509.3 mln -LSEG
** Co expects full-year adj. EPS to be in the range of $2.47
to $2.50, vs prior range of $2.53 to $2.57
** Analysts were expecting 2023 adj. EPS of $2.54 -LSEG
** Up to last close, stock down 33.8% YTD
(Reporting by Mariam Sunny in Bengaluru)
((Mariam.ESunny@thomsonreuters.com;))
Recent news on InMode
See all newsBrief: Inmode Haifa District Court Denied Sp Strategic Holdings' Request For Temporary Injunctive Relief In Its Entirety
InMode Ltd. reports results for the quarter ended June 30 - Earnings Summary
Brief: Inmode Q2 Revenue USD 95.589 Million Versus. Ibes Estimate USD 93 Million
InMode Q2 revenue beats estimates on steady U.S. demand
Brief: Steel Partners Urges Inmode Shareholders To Vote Against The Re-Election Of Dr. Hadar Ron And Against Extraordinary Special Committee Compensation At The July 30 Annual General Meeting